Florida Urological Society's 68th annual meeting -- Targeted biopsy techniques combining magnetic resonance imaging (MRI) and ultrasound can improve detection of significant prostate cancer (PCa) and could influence development of future criteria for active surveillance, according to a researcher.
A study suggests that female physicians do not use as many codes as their male counterparts, resulting in a reimbursement gap.
Use of 5α-reductase inhibitors (5ARIs) to treat benign prostatic hyperplasia (BPH) is associated with a significantly increased risk of sexual dysfunction.
Providers can be sued under state rules pertaining to privacy and negligence for breaches.
Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), reduced muscle mass, and lower levels of physical activity are associated with a greater likelihood of hypogonadism in men undergoing hemodialysis (HD).
Florida Urological Society's 68th annual meeting: Prostate artery embolization (PAE) has been emerging as a minimally invasive alternative for patients suffering from benign prostatic hyperplasia (BPH).
Florida Urological Society's 68th annual meeting: New assays and scoring systems can improve the accuracy of prostate cancer (PCa) screening, prognostication, and risk stratification compared with the use of PSA alone.
Existing cancer screening guidelines for solid organ transplant recipients fall short in several key ways, according to a new review.
Annette Bruchfeld, MD, PhD, discusses chronic HCV infection in the contexts of chronic kidney disease, dialysis, and transplantation.
Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.
Access our job board to view over 1,000 job openings throughout the US.
Tell us about your social media habits for a chance to win a free gift card.